Epic Test Fail Behind $4 Billion Rout Doesn\'t Faze Drugmaker
Epic Test Fail Behind $4 Billion Rout Doesn't Faze Drugmaker
(Bloomberg) -- When Keita Mori, co-founder of SanBio Co., heard the news in January that the company’s flagship drug candidate had failed a major test, he almost lost his cool.